Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms
This is a multi-center, prospective, propensity matched twin armed study conducted on 50
patients in the experimental arm followed for 18 months after intervention evaluating cost
effectiveness, safety and efficacy of therapy.
Age: 18 - 80 years
Gender: All
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially
available contemporary EVAR in a real-world population. Patients will be randomized into two
device cohorts and compared across the primary endpoints.
Patients will be ...
Age: 21 years - 66+
Gender: All
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry will be used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an arte...
Age: Birth - 120 years
Gender: All
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry will be used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an arte...
Age: Birth - 120 years
Gender: All
Post-Approval Study of the TREO Abdominal Stent-Graft System
The purpose of this study is to determine the long-term performance of the TREO Abdominal
Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or
Aorto-iliac Aneurysms.
Age: 18 years - 66+
Gender: All
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical gra...
Age: 18 years - 66+
Gender: All
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Prospective, non-randomized, , multicenter study with two independent arms:
- Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System.
Hypothesis-driven analysis.
- Up to 65 additional subjects may be implanted in Continued Access Phase un...
Age: 19 years - 66+
Gender: All
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Prospective, non-randomized, , multicenter study with two independent arms: - Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System. Hypothesis-driven analysis. - Secondary Study Arm - TAAA requiring TAMBE System and CTAG Device(s). Non hypothesis...
Age: 19 years - 66+
Gender: All
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
The ascending aorta conducts blood from the heart to the rest of the body. The ascending
aorta can become enlarged, and the risk of tearing and rupturing becomes higher with larger
aorta. When the ascending aorta tears or ruptures, the risk dying is high even if sur...
Age: 18 - 79 years
Gender: All
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
The ascending aorta conducts blood from the heart to the rest of the body. The ascending
aorta can become enlarged, and the risk of tearing and rupturing becomes higher with larger
aorta. When the ascending aorta tears or ruptures, the risk dying is high even if sur...
Age: 18 - 79 years
Gender: All
Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
The purpose of this study is to demonstrate effectiveness and safety of the CODMAN
ENTERPRISE® Vascular Reconstruction Device and Delivery System.
Age: 21 - 70 years
Gender: All